How Medicentre tenants have changed health
Alesi Surgical A university spin-out formerly known as Asalus, Alesi Surgical raised £5.2m in June 2017 following the approval of its Ultravision technology by both the US Food and Drug Administration and Japanese Ministry of Health.
Ultravision handles the smoke created during keyhole surgery in the abdomen. BioDynamics Research Acquired by Quotient in February 2008, BioDynamics Research was a leading provider of metabolism, bioanalytical and radiochemistry services to the pharmaceutical and biotechnology industries. Cardiff Bioanalytical Services A leading provider of External Quality Assessment schemes for clinical and forensic toxicology and therapeutic drug monitoring. It was acquired by LGC Standards in 2010. Cardiff Research Consortium A tenant from the Medicentre’s opening year, Cardiff Research Consortium provided analysis and consultancy services for pharmaceutical companies looking to determine the cost benefit of a particular drug regime.
It also supported drugs trials with an extensive outcomes research database. It was acquired by Capita Group plc for £11.6m in 2009. Indoor Biotechnologies Graduating in 2016, Indoor Biotechnologies specialises in innovative products and services for indoor air quality, environmental sciences, allergy and asthma.
The company’s products help detect the causes of allergies, including those from pollen, food, animals and mites. MedaPhor Another university spin-out, MedaPhor is a global provider of advanced ultrasound training simulators for medical professionals.
Its ScanTrainer simulator offers a self-learning ultrasound scanning experience that replicates being taught one-to-one by an expert. In September 2017, MedaPhor raised £5.5m through a share placing and acquired Oxford University spin-out Intelligent Ultrasound for £3.6m. Nemesis Bioscience Nemesis Bioscience develops products designed to resurrect anti-microbial therapies made ineffective by increasing microbial resistance. It secured £700,000 seed funding in May 2017 to develop its suite of Bacterial Cybergenetics technologies. OnExamination Formed by two doctors from the university, OnExamination provides a range of exam preparation materials for practitioners.
The company was acquired by the British Medical Journal in 2007. Q Chip A biopharmaceutical developing cancer therapy and ophthalmology products allowing for the sustained release of substances over extended periods of time. It was acquired by nanomedicine company Midatech Pharma in 2014 following its AIM listing. Synexus Clinical Research Synexus manages clinical trials and recruit patients for the process.
The largest organisation of its kinds in Europe, the company leased Medicentre space to establish its presence in Wales. It was taken private in 2007 by Lyceum Capital at a valuation of £18m. TrichoTech TrichoTech supplies drug and alcohol testing to legal courts. It was acquired by Concateno plc for £11.25m in 2007.